People with diabetes are unfortunately more predisposed to dementia, a condition impairing memory and cognitive abilities.
However, a new study sheds a promising light on this issue, suggesting that the diabetes drug, pioglitazone, might play a role in decreasing dementia risks in newly diagnosed type 2 diabetic patients.
A comprehensive study conducted in Korea involved monitoring a significant number of newly diagnosed type 2 diabetic individuals, sans dementia, over a decade.
The study was designed to observe any developing patterns between the administration of pioglitazone and the occurrence of dementia.
Results Highlight:
- Of the 91,000+ participants, a subset took pioglitazone.
- 8.3% of pioglitazone users developed dementia, compared to 10.0% of non-users.
- Calculatively, this drug diminished dementia risks by 16%.
Longer Usage, Lower Risks
The study underscored an inverse relation between the duration of pioglitazone intake and dementia risks:
- Four-year-long users exhibited a staggering 37% reduced risk.
- Even a span of 1-2 years showcased a 22% decline in risk.
Interestingly, pioglitazone intake was also linked with decreased stroke risks, a concern commonly associated with diabetes.
Maximum Beneficiaries
People with a medical background of ischemic heart disease or stroke seemed to gain the most from pioglitazone:
Ischemic heart disease sufferers saw a 54% risk reduction.
Prior stroke patients experienced a 43% risk reduction.
Pondering Points and Future Directions
While the study is promising, it’s essential to clarify that it signifies a correlation, not necessarily causation.
Pioglitazone does come with its share of side effects, including swelling and weight gain. As such, the long-term safety and efficacy of the drug require more rigorous exploration.
There’s also a necessity for additional research to:
- Corroborate these findings.
- Establish an optimal dosage balancing benefits against potential side effects.
Final Thoughts
The relationship between pioglitazone and decreased dementia risks provides a beacon of hope for individuals diagnosed with type 2 diabetes. However, medical consultation is pivotal before initiating any new medication.
As research advances, we hope to unearth more strategies to safeguard cognitive health and ameliorate the quality of life for diabetics.
For those keen on diabetes, recent studies have indicated potential benefits of the MIND diet for vision loss diseases and how Vitamin D might alleviate diabetic neuropathic pain.
Additionally, other studies suggest Vitamin E as a potential remedy to counter blood sugar and insulin resistance, and consuming eggs as part of a healthy diet may lower diabetes and high blood pressure risks.
This enlightening study found its home in the journal, Neurology.
If you care about diabetes, please read studies about best way to achieve type 2 diabetes remission, and oranges may hold the key to reducing obesity and diabetes.
For more information about weight loss, please see recent studies that Mediterranean diet can reduce belly fat much better, and Keto diet could help control body weight and blood sugar in diabetes.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
